Melville, NY, United States of America

Lifu Ma


Average Co-Inventor Count = 19.2

ph-index = 1

Forward Citations = 28(Granted Patents)


Location History:

  • Farmingdale, NY (US) (2008)
  • Melville, NY (US) (2013)

Company Filing History:


Years Active: 2008-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lifu Ma: Innovator in Chemical Compounds

Introduction

Lifu Ma is an accomplished inventor based in Melville, NY, recognized for his contributions to the field of chemical compounds. With a total of 2 patents to his name, Ma has made significant strides in developing innovative solutions in his area of expertise.

Latest Patents

Among Lifu Ma's most notable inventions are his latest patents, which include 7-aminofuropyridine derivatives, specifically compounds of Formula 1. In addition, he has developed substituted pyrrolo[2.3-B]pyridines represented by Formula (I). These inventions showcase his capability to create important chemical structures that could have various applications in pharmaceuticals.

Career Highlights

Lifu Ma currently works at Osi Pharmaceuticals, Inc., where he applies his skills and knowledge to advance his research and innovation in chemical compounds. His work has contributed to the company’s reputation as a leader in the pharmaceutical industry, focusing on innovative therapies.

Collaborations

Throughout his career, Lifu Ma has collaborated with fellow professionals, including Bijoy Panicker and An-Hu Li. These partnerships underscore the importance of teamwork in scientific research and development, allowing for the exchange of ideas and expertise.

Conclusion

Lifu Ma continues to exemplify the spirit of innovation through his patents and collaborations. His work at Osi Pharmaceuticals, Inc. reflects a commitment to advancing chemical research and discovering new therapeutic options. With ongoing developments, Lifu Ma remains a significant contributor to the field of chemical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…